APA (7th ed.) Citation

J, G., MS, N., B, A., F, G., M, H., D, d. S., . . . R, L. (2021). Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction. Scientific reports, 11(1), 10882. https://doi.org/10.1038/s41598-021-90333-0

Chicago Style (17th ed.) Citation

J, Guiot, Njock MS, André B, Gester F, Henket M, de Seny D, Moermans C, Malaise MG, and Louis R. "Serum IGFBP-2 in Systemic Sclerosis as a Prognostic Factor of Lung Dysfunction." Scientific Reports 11, no. 1 (2021): 10882. https://doi.org/10.1038/s41598-021-90333-0.

MLA (9th ed.) Citation

J, Guiot, et al. "Serum IGFBP-2 in Systemic Sclerosis as a Prognostic Factor of Lung Dysfunction." Scientific Reports, vol. 11, no. 1, 2021, p. 10882, https://doi.org/10.1038/s41598-021-90333-0.